Review
doi: 10.1002/cld.721.
eCollection 2018 Aug.
The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
Affiliations
- PMID: 30988909
- PMCID: PMC6385911
- DOI: 10.1002/cld.721
Item in Clipboard
Review
The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
Clin Liver Dis (Hoboken).
.
No abstract available
Figures
Proposed algorithm to screen for and manage metabolic risk factors in patients with NAFLD. Abbreviation: LDL, low‐density lipoprotein.
Similar articles
-
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes.SAGE Open Med. 2020 Jun 20;8:2050312120933804. doi: 10.1177/2050312120933804. eCollection 2020. SAGE Open Med. 2020. PMID: 32612827 Free PMC article. Review.
-
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.Liver Int. 2019 Feb;39(2):342-352. doi: 10.1111/liv.13992. Epub 2018 Dec 4. Liver Int. 2019. PMID: 30347513
-
Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis.Am J Med. 2018 Dec;131(12):1515.e1-1515.e10. doi: 10.1016/j.amjmed.2018.07.011. Epub 2018 Aug 1. Am J Med. 2018. PMID: 30075104
-
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.Clin Investig Arterioscler. 2017 Jul-Aug;29(4):185-200. doi: 10.1016/j.arteri.2016.06.002. Epub 2016 Sep 28. Clin Investig Arterioscler. 2017. PMID: 27692632 Review. English, Spanish.
-
[Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Jan;36(1):40-4. Zhonghua Liu Xing Bing Xue Za Zhi. 2015. PMID: 25876863 Chinese.
Cited by
-
Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice.Heliyon. 2024 Feb 1;10(3):e25460. doi: 10.1016/j.heliyon.2024.e25460. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38356602 Free PMC article.
-
New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk.Diagnostics (Basel). 2024 Jan 22;14(2):229. doi: 10.3390/diagnostics14020229. Diagnostics (Basel). 2024. PMID: 38275476 Free PMC article. Review.
-
Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease.Dig Dis Sci. 2023 Sep;68(9):3765-3773. doi: 10.1007/s10620-023-07987-1. Epub 2023 Jul 1. Dig Dis Sci. 2023. PMID: 37392337
-
Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification.Front Pharmacol. 2023 Jan 24;14:1082451. doi: 10.3389/fphar.2023.1082451. eCollection 2023. Front Pharmacol. 2023. PMID: 36762105 Free PMC article.
-
Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease.Front Endocrinol (Lausanne). 2022 Dec 16;13:1071350. doi: 10.3389/fendo.2022.1071350. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36589844 Free PMC article.
References
-
- Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: A population‐based cohort study. Gastroenterology 2005;129:113‐121. - PubMed
-
- Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865‐873. - PubMed
-
- Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413‐1419. - PubMed
-
- Targher G, Day CP, Bonora B. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341‐1350. - PubMed
-
- Wong VW‐S, Wong GL, Yeung JC, Fung CY, Chan JK, Chang ZH, et al. Long‐term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study. Hepatology 2016;63:754‐763. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
